Skip to main content

 Scientific publications

Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients.

Authors : Lambertini M, Campbell C, Bines J, Korde LA, Izquierdo M, Fumagalli D, Del Mastro L, Ignatiadis M, Pritchard K, Wolff AC, Jackisch C, Lang I, Untch M, Smith I, Boyle F, Xu B, Barrios CH, Baselga J, Moreno-Aspitia A, Piccart-Gebhart M, Gelber Rd, de Azambuja E
Year : 2019
Journal : J Natl Cancer Inst
Volume : 111
Pages : 86-94

Quality management for systemic treatment of breast cancer

Authors : Verhoeven D, Duhoux FP, de Azambuja E, Wildiers H, Vuylsteke P, Barbeaux A, Van Damme N, Van Eycken E
Year : 2018
Journal : Belgian J Medical Oncology
Volume : 11(1)
Pages : 15-21

Breast cancer and pregnancy-related issues.

Authors : Lambertini M, Nguyen B, Viglietti G, Martel S, de Azambuja E
Year : 2018
Journal : Belgian J Medical Oncology
Volume : 11(1)
Pages : 9-14

Risk factors for the development of brain metastases in patients with HER2-positive breast cancer.

Authors : Maurer C, Tulpin L, Moreau M, Dumitrescu C, de Azambuja E, Paesmans M, Nogaret JM, Piccart-Gebhart M, Awada A
Year : 2018
Journal : ESMO Open
Volume : 3
Pages : e000440

In Reply to Belkacemi and Tsoutsou.

Authors : Zeidan YH, Habib JG, de Azambuja E, Campbell I, Andersson M, Lluch A, Di Leo A, Francis PA
Year : 2018
Journal : Int J Radiat Oncol Biol Phys
Volume : 102
Pages : 467-468

CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion.

Authors : Preusser M, De Mattos-Arruda L, Thill M, Criscitiello C, Bartsch R, Ruhstaller T, de Azambuja E, Zielinski CC
Year : 2018
Journal : ESMO Open
Volume : 3
Pages : e000368

Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis.

Authors : Poggio F, Bruzzone M, Ceppi M, Conte B, Martel S, Maurer C, Tagliamento M, Viglietti G, Del Mastro L, de Azambuja E, Lambertini M
Year : 2018
Journal : ESMO Open
Volume : 3
Pages : e000361

Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis.

Authors : Poggio F, Bruzzone M, Ceppi M, Pondé NF, La Valle G, Del Mastro L, de Azambuja E, Lambertini M
Year : 2018
Journal : Ann Oncol
Volume : 29
Pages : 1497-1508

Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis.

Authors : Debiasi M, Polanczyk CA, Ziegelmann P, Barrios C, Cao H, Dignam JJ, Goss P, Bychkovsky B, Finkelstein DM, Guindalini RS, Filho P, Albuquerque C, Reinert T, de Azambuja E, Olopade O
Year : 2018
Journal : Front Oncol
Volume : 8
Pages : 156

Association of T-Cell Receptor Repertoire Use With Response to Combined Trastuzumab-Lapatinib Treatment of HER2-Positive Breast Cancer: Secondary Analysis of the NeoALTTO Randomized Clinical Trial.

Authors : Powles RL, Redmond D, Sotiriou C, Loi S, Fumagalli D, Nuciforo P, Harbeck N, de Azambuja E, Sarp S, Di Cosimo S, Huober J, Baselga J, Piccart-Gebhart M, Elemento O, Pusztai L, Hatzis C
Year : 2018
Journal : JAMA Oncol
Volume : 4
Pages : e181564

Radiological evaluation of response to immunotherapy in brain tumors: Where are we now and where are we going?

Authors : Porcu M, Solinas C, Garofalo P, de Azambuja E, Scartozzi M, Willard-Gallo K, Preusser M, Saba L
Year : 2018
Journal : Crit Rev Oncol Hematol
Volume : 126
Pages : 135-144

Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?

Authors : Lambertini M, Viglietti G, de Azambuja E
Year : 2018
Journal : ESMO Open
Volume : 3
Pages : e000350

Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects.

Authors : Brandão M, Pondé NF, Poggio F, Kotecki N, Salis M, Lambertini M, de Azambuja E
Year : 2018
Journal : Expert Rev Anticancer Ther
Volume : 18
Pages : 629-649

Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients.

Authors : Lambertini M, Goldrat O, Ferreira AR, Dechene J, Azim HA Jr, Desir J, Delbaere A, Tkint de Roodenbeke D, de Azambuja E, Ignatiadis M, Demeestere I
Year : 2018
Journal : Ann Oncol
Volume : 29(1)
Pages : 237-243

Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status.

Authors : Lambertini M, Kroman N, Ameye L, Cordoba O, Pinto A, Benedetti G, Jensen MB, Gelber S, Del Grande M, Ignatiadis M, de Azambuja E, Paesmans M, Peccatori FA, Azim HA Jr
Year : 2018
Journal : J Natl Cancer Inst
Volume : 110(4)
Pages : 426-429

Association of p27 and cyclin D1 expression and benefit from adjuvant trastuzumab treatment in HER2-positive early breast cancer: a TransHERA study.

Authors : Filipits M, Dafni U, Gnant M, Polydoropoulou V, Hills M, Kiermaier A, de Azambuja E, Larsimont D, Rojo F, Viale G, Toi M, Harbeck N, Pritchard KI, Gelber Rd, Dinh P, Zardavas D, Leyland-Jones B, Piccart-Gebhart M, Dowsett M
Year : 2018
Journal : Clin Cancer Res
Volume : 24(13)
Pages : 3079-3086

Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial.

Authors : Zeidan YH, Habib JG, Ameye L, Paesmans M, de Azambuja E, Gelber Rd, Campbell I, Nordenskjöld B, Gutiérez J, Anderson M, Lluch A, Gnant M, Goldhirsch A, Di Leo A, Joseph DJ, Crown J, Piccart-Gebhart M, Francis PA
Year : 2018
Journal : Int J Radiat Oncol Biol Phys
Volume : 101(2)
Pages : 316-324.

Endocrine therapy and palbociclib within a compassionate use program in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer.

Authors : Maurer C, Ferreira AR, Martel S, Lambertini M, Pondé N, Aftimos P, de Azambuja E, Piccart-Gebhart M
Year : 2018
Journal : Breast
Volume : 39
Pages : 14-18

Surgery of the primary tumour in patients presenting with de novo metastatic breast cancer: to do or not to do?

Authors : Poggio F, Lambertini M, de Azambuja E
Year : 2018
Journal : ESMO Open
Volume : 3
Pages : e000324

Choice of chemotherapy regimen for early HER2-positive breast cancer in elderly patients.

Authors : Pondé N, de Azambuja E
Year : 2018
Journal : Chin Clin Oncol
Volume : 7(1)
Pages : 4